Highlights
KLSE: NEXGRAM (0096)       NEXGRAM HOLDINGS BHD ACE : Telco&Media
Last Price Today's Change   Day's Range   Trading Volume
0.045   0.00 (0.00%)  0.045 - 0.05  5,938,600
Trade this stock and win a FREE I3investor T-shirt after 5 trades. Find out more.

Financials


Market Cap: 100 Million

Market Cap 100 Million
NOSH 2,230 Million

Latest Audited Result:  31-Jul-2020

Latest Audited Result: 31-Jul-2020
Announcement Date 24-Nov-2020
Next Audited Result: 31-Jul-2021
Est. Ann. Date: 24-Nov-2021
Est. Ann. Due Date: 27-Jan-2022

Latest Quarter:  31-Oct-2020 [#1]

Latest Quarter: 31-Oct-2020 [#1]
Announcement Date 30-Dec-2020
Next Quarter: 31-Jan-2021
Est. Ann. Date: 30-Mar-2021
Est. Ann. Due Date: 01-Apr-2021
QoQ | YoY   95.53%  |    -4,077.61%

Annual (Unaudited) ( EPS: -2.78, P/E: -1.62 )

Revenue | NP to SH 41,277  |  -61,890
RPS | P/RPS 1.85 Cent  |  2.43
EPS | P/E | EY -2.78 Cent  |  -1.62  |  -61.67%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 0.04  |  1.10
YoY   -182.44%
NP Margin | ROE -148.92%  |  -68.00%
F.Y. | Ann. Date 31-Jul-2020  |  29-Sep-2020

T4Q Result ( EPS: -2.89, P/E: -1.56 )

Revenue | NP to SH 42,220  |  -64,527
RPS | P/RPS 1.89 Cent  |  2.38
EPS | P/E | EY -2.89 Cent  |  -1.56  |  -64.30%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 0.05  |  0.92
QoQ | YoY   -4.42%  |    -146.15%
NP Margin | ROE -153.44%  |  -59.29%
F.Y. | Ann. Date 31-Oct-2020  |  30-Dec-2020

Annualized Result ( EPS: -0.48, P/E: -9.41 )

Revenue | NP to SH 51,784  |  -10,660
RPS | P/RPS 2.32 Cent  |  1.94
EPS | P/E | EY -0.48 Cent  |  -9.41  |  -10.62%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   82.78%  |    -4,077.61%
NP Margin | ROE -21.74%  |  -9.80%
F.Y. | Ann. Date 31-Oct-2020  |  30-Dec-2020


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Jul-2021 30-Dec-2020 31-Oct-2020 1 12,946 -2,838 -2,814 -2,665 - 108,827 - % -21.74% -2.45% 2,230,081 0.58 0.58 -0.12 -0.12 0.00 0.00 0.0488 0.05   95.69%   -4,077.61% 30-Oct-2020 0.035 6.03 -29.29 0.72 -3.41% 0.00% 30-Dec-2020 0.045 7.75 -37.66 0.92 -2.66% 0.00%
31-Jul-2020 29-Sep-2020 31-Jul-2020 4 41,277 -62,264 -61,469 -61,890 - 91,013 - % -148.92% -68.00% 2,661,204 1.55 1.85 -2.33 -2.78 0.00 0.00 0.0342 0.04   -2,566.52%   -182.44% 30-Jul-2020 0.055 3.55 -2.36 1.61 -42.28% 0.00% 29-Sep-2020 0.045 2.90 -1.93 1.32 -51.68% 0.00%
31-Jul-2020 30-Jun-2020 30-Apr-2020 3 25,438 -2,290 -2,401 -2,321 - 148,919 - % -9.44% -1.56% 2,071,204 1.23 1.14 -0.11 -0.10 0.00 0.00 0.0719 0.07   -47.74%   -316.11% 30-Apr-2020 0.015 1.22 -13.39 0.21 -7.47% 0.00% 30-Jun-2020 0.025 2.04 -22.31 0.35 -4.48% 0.00%
31-Jul-2020 30-Mar-2020 31-Jan-2020 2 20,941 -1,095 -1,213 -1,571 - 147,262 - % -5.79% -1.07% 2,071,204 1.01 0.94 -0.08 -0.07 0.00 0.00 0.0711 0.07   -2,444.78%   86.77% 31-Jan-2020 0.015 1.48 -19.78 0.21 -5.06% 0.00% 30-Mar-2020 0.005 0.49 -6.59 0.07 -15.17% 0.00%
31-Jul-2020 30-Dec-2019 31-Oct-2019 1 12,003 477 500 67 - 125,514 - % 4.17% 0.05% 2,071,204 0.58 0.54 0.00 0.00 0.00 0.00 0.0606 0.06   100.31%   106.96% 31-Oct-2019 0.015 2.59 463.70 0.25 0.22% 0.00% 30-Dec-2019 0.01 1.73 309.13 0.17 0.32% 0.00%
31-Jul-2019 30-Sep-2019 31-Jul-2019 4 58,341 -20,288 -21,841 -21,913 - 12,339,400 - % -37.44% -0.18% 2,053,144 2.84 2.62 -1.07 -0.98 0.00 0.00 6.0100 5.53   -2,140.32%   62.13% 31-Jul-2019 0.015 0.53 -1.41 0.00 -71.15% 0.00% 30-Sep-2019 0.015 0.53 -1.41 0.00 -71.15% 0.00%
31-Jul-2019 28-Jun-2019 30-Apr-2019 3 42,326 1,319 1,357 1,074 - 14,789,558 - % 3.21% 0.01% 2,017,675 2.10 1.90 0.05 0.05 0.00 0.00 7.3300 6.63   109.04%   111.62% 30-Apr-2019 0.02 0.95 37.57 0.00 2.66% 0.00% 28-Jun-2019 0.015 0.72 28.18 0.00 3.55% 0.00%
31-Jul-2019 22-Mar-2019 31-Jan-2019 2 26,652 -166 -136 -11,876 - 14,446,936 - % -0.51% -0.08% 1,973,625 1.35 1.20 -0.04 -0.53 0.00 0.00 7.3200 6.48   -1,133.23%   -90.56% 31-Jan-2019 0.015 1.11 -2.49 0.00 -40.12% 0.00% 22-Mar-2019 0.015 1.11 -2.49 0.00 -40.12% 0.00%
31-Jul-2019 28-Dec-2018 31-Oct-2018 1 11,651 -624 -587 -963 - 14,928,214 - % -5.04% -0.01% 1,926,221 0.60 0.52 -0.05 -0.04 0.00 0.00 7.7500 6.69   98.34%   66.76% 31-Oct-2018 0.02 3.31 -40.00 0.00 -2.50% 0.00% 28-Dec-2018 0.02 3.31 -40.00 0.00 -2.50% 0.00%
31-Jul-2018 02-Oct-2018 31-Jul-2018 4 45,638 -57,581 -57,877 -57,864 - 142,645 - % -126.82% -40.57% 1,896,876 2.41 2.05 -3.05 -2.59 0.00 0.00 0.0752 0.06   -525.96%   -257.41% 31-Jul-2018 0.03 1.25 -0.98 0.40 -101.68% 0.00% 02-Oct-2018 0.025 1.04 -0.82 0.33 -122.02% 0.00%
31-Jul-2018 27-Jun-2018 30-Apr-2018 3 32,392 -16,465 -9,226 -9,244 - 187,522 - % -28.48% -4.93% 1,865,896 1.74 1.45 -0.50 -0.41 0.00 0.00 0.1005 0.08   -48.33%   -5.46% 30-Apr-2018 0.065 3.74 -13.12 0.65 -7.62% 0.00% 27-Jun-2018 0.035 2.02 -7.06 0.35 -14.15% 0.00%
31-Jul-2018 30-Mar-2018 31-Jan-2018 2 20,920 -6,241 -6,195 -6,232 - 18,808,232 - % -29.61% -0.03% 1,865,896 1.12 0.94 -0.33 -0.28 0.00 0.00 10.0800 8.43   -115.12%   26.58% 30-Jan-2018 0.035 3.12 -10.48 0.00 -9.54% 0.00% 30-Mar-2018 0.05 4.46 -14.97 0.00 -6.68% 0.00%
31-Jul-2018 29-Dec-2017 31-Oct-2017 1 10,581 -2,384 -2,338 -2,897 - 19,405,318 - % -22.10% -0.01% 1,865,896 0.57 0.47 -0.16 -0.13 0.00 0.00 10.4000 8.70   82.11%   -25.90% 31-Oct-2017 0.035 6.17 -22.54 0.00 -4.44% 0.00% 29-Dec-2017 0.035 6.17 -22.54 0.00 -4.44% 0.00%
31-Jul-2017 29-Sep-2017 31-Jul-2017 4 53,162 -11,363 -16,852 -16,190 - 19,853,135 - % -31.70% -0.08% 1,865,896 2.85 2.38 -0.87 -0.73 0.00 0.00 10.6400 8.90   -84.71%   - % 31-Jul-2017 0.04 1.40 -4.61 0.00 -21.69% 0.00% 29-Sep-2017 0.04 1.40 -4.61 0.00 -21.69% 0.00%
31-Jul-2017 23-Jun-2017 30-Apr-2017 3 34,602 -9,626 -9,666 -8,765 - 208,234 - % -27.93% -4.21% 1,865,896 1.85 1.55 -0.47 -0.39 0.00 0.00 0.1116 0.09   -3.26%   -136.94% 28-Apr-2017 0.045 2.43 -9.58 0.40 -10.44% 0.00% 23-Jun-2017 0.045 2.43 -9.58 0.40 -10.44% 0.00%
31-Jul-2017 31-Mar-2017 31-Jan-2017 2 23,091 -9,190 -9,147 -8,488 - 209,353 - % -39.61% -4.05% 1,865,896 1.24 1.04 -0.45 -0.38 0.00 0.00 0.1122 0.09   -268.88%   - % 31-Jan-2017 0.035 2.83 -7.69 0.31 -13.00% 0.00% 31-Mar-2017 0.055 4.44 -12.09 0.49 -8.27% 0.00%
31-Jul-2017 12-Jan-2017 31-Oct-2016 1 13,432 -2,257 -2,219 -2,301 - 214,204 - % -16.52% -1.07% 1,865,896 0.72 0.60 -0.12 -0.10 0.00 0.00 0.1148 0.10   - %   -167.98% 31-Oct-2016 0.045 6.25 -36.49 0.39 -2.74% 0.00% 12-Jan-2017 0.045 6.25 -36.49 0.39 -2.74% 0.00%
31-Jul-2016 30-Sep-2016 31-Jul-2016 4 0 0 0 0 - 21,894,014 - % - % - % 1,876,093 - - 0.00 0.00 - - 11.6700 9.82   - %   - % 29-Jul-2016 0.05 0.00 0.00 0.00 0.00% 0.00% 30-Sep-2016 0.045 0.00 0.00 0.00 0.00% 0.00%
31-Jul-2016 29-Jun-2016 30-Apr-2016 3 96,597 24,029 23,864 23,725 - 229,590 - % 24.70% 10.33% 1,868,110 5.17 4.33 1.27 1.06 0.00 0.00 0.1229 0.10   - %   241.66% 29-Apr-2016 0.055 1.06 4.33 0.45 23.09% 0.00% 29-Jun-2016 0.055 1.06 4.33 0.45 23.09% 0.00%
30-Apr-2016 29-Mar-2016 31-Jan-2016 2 0 0 0 0 - 232,620 - % - % - % 1,863,945 - - 0.00 0.00 0.00 0.00 0.1248 0.10   - %   - % 29-Jan-2016 0.065 0.00 0.00 0.52 0.00% 0.00% 29-Mar-2016 0.06 0.00 0.00 0.48 0.00% 0.00%
30-Apr-2016 31-Dec-2015 31-Oct-2015 2 57,776 3,801 3,795 3,385 - 256,695 - % 6.57% 1.32% 1,880,555 3.07 2.59 0.18 0.15 0.00 0.00 0.1365 0.12   - %   127.79% 30-Oct-2015 0.075 2.44 41.67 0.55 2.40% 0.00% 31-Dec-2015 0.095 3.09 52.78 0.70 1.89% 0.00%
30-Apr-2016 30-Sep-2015 31-Jul-2015 0 0 0 0 - 226,745 - % - % - % 1,710,000 - - 0.00 0.00 0.00 0.00 0.1326 0.10   - %   - % 31-Jul-2015 0.095 0.00 0.00 0.72 0.00% 0.00% 30-Sep-2015 0.07 0.00 0.00 0.53 0.00% 0.00%
30-Apr-2015 30-Jun-2015 30-Apr-2015 134,373 14,167 9,050 6,944 - 194,629 - % 6.73% 3.57% 1,453,541 9.24 6.03 0.38 0.31 0.00 0.00 0.1339 0.09   41.77%   -50.50% 30-Apr-2015 0.115 1.24 24.07 0.86 4.15% 0.00% 30-Jun-2015 0.10 1.08 20.93 0.75 4.78% 0.00%
30-Apr-2015 24-Mar-2015 31-Jan-2015 3 115,995 7,944 7,941 4,898 - 195,775 - % 6.85% 2.50% 1,440,588 8.05 5.20 0.34 0.22 0.00 0.00 0.1359 0.09   229.61%   -3.77% 30-Jan-2015 0.075 0.93 22.06 0.55 4.53% 0.00% 24-Mar-2015 0.115 1.43 33.82 0.85 2.96% 0.00%
30-Apr-2015 30-Dec-2014 31-Oct-2014 2 49,204 3,264 3,264 1,486 - 102,455 - % 6.63% 1.45% 782,105 6.29 2.21 0.19 0.07 0.00 0.00 0.1310 0.05   -0.47%   -48.76% 31-Oct-2014 0.115 1.83 60.53 0.88 1.65% 0.00% 30-Dec-2014 0.07 1.11 36.84 0.53 2.71% 0.00%
30-Apr-2015 30-Sep-2014 31-Jul-2014 1 24,229 2,010 2,010 1,493 - 215,489 - % 8.30% 0.69% 1,658,888 1.46 1.09 0.09 0.07 0.00 0.00 0.1299 0.10   -89.36%   -2.10% 31-Jul-2014 0.12 8.22 133.33 0.92 0.75% 0.00% 30-Sep-2014 0.125 8.56 138.89 0.96 0.72% 0.00%
30-Apr-2014 30-Jun-2014 30-Apr-2014 4 102,050 14,951 14,946 14,028 - 98,954 - % 14.65% 14.18% 758,270 13.46 4.58 1.85 0.63 0.00 0.00 0.1305 0.04   175.60%   90.65% 30-Apr-2014 0.12 0.89 6.49 0.92 15.42% 0.00% 30-Jun-2014 0.11 0.82 5.95 0.84 16.82% 0.00%
30-Apr-2014 28-Mar-2014 31-Jan-2014 3 79,896 5,076 5,070 5,090 - 184,737 - % 6.35% 2.76% 748,529 10.67 3.58 0.68 0.23 0.00 0.00 0.2468 0.08   75.52%   9.27% 30-Jan-2014 0.08 0.75 11.76 0.32 8.50% 0.00% 28-Mar-2014 0.13 1.22 19.12 0.53 5.23% 0.00%
30-Apr-2014 26-Dec-2013 31-Oct-2013 2 52,063 2,874 2,874 2,900 - 129,247 - % 5.52% 2.24% 659,090 7.90 2.33 0.44 0.13 0.00 0.00 0.1961 0.06   90.16%   6.93% 31-Oct-2013 0.09 1.14 20.45 0.46 4.89% 0.00% 26-Dec-2013 0.075 0.95 17.05 0.38 5.87% 0.00%
30-Apr-2014 26-Sep-2013 31-Jul-2013 1 24,979 1,424 1,424 1,525 - 88,776 - % 5.70% 1.72% 544,642 4.59 1.12 0.28 0.07 0.00 0.00 0.1630 0.04   -79.27%   16.86% 31-Jul-2013 0.085 1.85 30.36 0.52 3.29% 0.00% 26-Sep-2013 0.085 1.85 30.36 0.52 3.29% 0.00%
30-Apr-2013 28-Jun-2013 30-Apr-2013 4 79,677 6,593 6,587 7,358 - 89,882 - % 8.27% 8.19% 545,736 14.60 3.57 1.27 0.33 0.00 0.00 0.1647 0.04   57.96%   -7.77% 30-Apr-2013 0.085 0.58 6.30 0.52 15.86% 0.00% 28-Jun-2013 0.085 0.58 6.30 0.52 15.86% 0.00%
30-Apr-2013 21-Mar-2013 31-Jan-2013 3 53,168 4,666 4,690 4,658 - 100,294 - % 8.82% 4.64% 589,620 9.02 2.38 0.79 0.21 0.00 0.00 0.1701 0.05   71.76%   -17.47% 31-Jan-2013 0.095 1.05 12.03 0.56 8.32% 0.00% 21-Mar-2013 0.085 0.94 10.76 0.50 9.29% 0.00%
30-Apr-2013 24-Dec-2012 31-Oct-2012 2 34,166 2,792 2,815 2,712 - 77,177 - % 8.24% 3.51% 459,661 7.43 1.53 0.59 0.12 0.00 0.00 0.1679 0.03   107.82%   -25.23% 31-Oct-2012 0.12 1.61 20.34 0.71 4.92% 0.00% 24-Dec-2012 0.10 1.35 16.95 0.60 5.90% 0.00%
30-Apr-2013 01-Oct-2012 31-Jul-2012 1 16,607 1,395 1,305 1,305 - 104,897 - % 7.86% 1.24% 621,428 2.67 0.74 0.21 0.06 0.00 0.00 0.1688 0.05   -83.64%   -61.30% 31-Jul-2012 0.10 3.74 47.62 0.59 2.10% 0.00% 01-Oct-2012 0.09 3.37 42.86 0.53 2.33% 0.00%
30-Apr-2012 28-Jun-2012 30-Apr-2012 4 62,901 6,897 6,897 7,978 - 69,415 - % 10.96% 11.49% 406,892 15.46 2.82 1.89 0.36 0.00 0.00 0.1706 0.03   41.35%   561.53% 30-Apr-2012 0.10 0.65 5.10 0.59 19.61% 0.00% 28-Jun-2012 0.09 0.58 4.59 0.53 21.79% 0.00%
30-Apr-2012 29-Mar-2012 31-Jan-2012 3 47,384 5,744 5,644 5,644 - 71,877 - % 11.91% 7.85% 414,999 11.42 2.12 1.36 0.25 0.00 0.00 0.1732 0.03   55.61%   886.71% 31-Jan-2012 0.10 0.88 7.35 0.58 13.60% 0.00% 29-Mar-2012 0.10 0.88 7.35 0.58 13.60% 0.00%
30-Apr-2012 28-Dec-2011 31-Oct-2011 2 29,355 3,637 3,627 3,627 - 73,014 - % 12.36% 4.97% 431,785 6.80 1.32 0.84 0.16 0.00 0.00 0.1691 0.03   7.56%   1,253.36% 31-Oct-2011 0.05 0.74 5.95 0.30 16.80% 0.00% 28-Dec-2011 0.06 0.88 7.14 0.35 14.00% 0.00%
30-Apr-2012 27-Sep-2011 31-Jul-2011 1 14,483 3,372 3,372 3,372 - 74,494 - % 23.28% 4.53% 443,684 3.26 0.65 0.76 0.15 0.00 0.00 0.1679 0.03   179.60%   3,238.61% 29-Jul-2011 0.05 1.53 6.58 0.30 15.20% 0.00% 27-Sep-2011 0.04 1.23 5.26 0.24 19.00% 0.00%
30-Apr-2011 29-Jun-2011 30-Apr-2011 4 72,311 1,225 1,206 1,206 - 80,587 - % 1.67% 1.50% 511,666 14.13 3.24 0.26 0.05 0.00 0.00 0.1575 0.04   110.84%   -73.15% 29-Apr-2011 0.05 0.35 21.21 0.32 4.71% 0.00% 29-Jun-2011 0.05 0.35 21.21 0.32 4.71% 0.00%
30-Apr-2011 29-Mar-2011 31-Jan-2011 3 55,243 775 756 572 - 63,900 - % 1.37% 0.90% 408,571 13.52 2.48 0.14 0.03 0.00 0.00 0.1564 0.03   113.43%   -84.85% 31-Jan-2011 0.05 0.37 35.71 0.32 2.80% 0.00% 29-Mar-2011 0.05 0.37 35.71 0.32 2.80% 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  44 people like this.
 
MadCow75 tired jo... no power at all... all counter up it maintain.. all counter drop it drop...
13/01/2021 12:03 AM
Money_Lover This company very lousy in promoting itself. The directors think just post news is enough. You are a listed company lah dey, you have to sell and market yourself so ppl will buy your stock and you get more working capital to grow.
13/01/2021 8:20 AM
Orlando Stil can't see CN 13 status is d problem ??

No banks want to or can lend money to operators to goreng a CN13 co tat is why cannot go up
13/01/2021 8:34 AM
DRwarrant TO STEAM ANYTIME $$$$$$
13/01/2021 9:15 AM
MZM2511 @Orlando. Nexgram belum di senarai sebagai GN3 kerana ianya telah diberi relief untuk satu tahun. Berikut pandangan saya berkaitan risiko GN3 status bagi nexgram:

......Nexgram will not be classified as a GN3 listed issuer and will not be required to comply with the obligations pursuant to Rule 8.04 and GN3 of the ACE LR for a period of 12 months from the date of this announcement. Nexgram will re-assess its condition and announce whether it continues to trigger any of the criteria in GN3 of the ACE LR upon the expiry of the 12 months from the date of this announcement.

1. MUGC untuk tahun kewangan berakhir 2019 inilah yang buat BURSA triger GN3 dalam tahun kewangan berakhir 2020.
Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3007846
2. MUGC wujud dalam tahun kewangan berakhir 2019, itulah sebab mengapa ia menjadi calon GN3 berdasarkan MUGC tersebut (tetapi telah DIBERI RELIEF UNTUK SATU TAHUN). Relief tersebut akan dinilai kembali selepas tempoh satui tahun. Bermakna apabila selepas satu tahun dan keadaan yang menyebabkabkan MUCG pada tahun kewangan 2019 pulih, maka Nexgram tidak akan diklasifikasikan di bawah GN3.
4. Sebagai contoh berdasarkan laporan Q1 2021:
Nexgram's share holders equity on consolidated basis of its shares (excluding treasury shares): As per QR1 2021 report = RM108 879 189 / RM 212 519 923 = 51.23 % and As per QR4 2020 report = RM89 221 297 / RM 206 519 923 = 43.20 %
We can see that the percentage of shareholders equity of its shares was increased and surpassed 50%.
5 The company's condition is better in near future, the percentage of shareholders equity of its shares is more than 50%, no more MUGC will be triggered in 2020, no more worry about GN3 listed issuer.
Jadi, GN3 untuk Nexgram dalam jangka pendek ini bagi saya adalah slim chance.
13/01/2021 9:25 AM
MZM2511 @Orlando. Nexgram FA sehingga last QR masih lagi tidak baik. Saya setuju, jika anda menyatakan bahawa pihak bank sukar untuk beri kemudahan margin untuk membeli saham yang FA nya kurang baik. Kalau ada pengecualian pun mungkin untuk sesetengah syarikat tertentu sahaja.
13/01/2021 9:28 AM
MZM2511 Informations gathered from the QA at AGM 2020:
1. The company expected to turn profitable earliest in the FY2021.
2. The medical division will potentially contribute to the company growth in near future. A little explanation about the vaccine JV.
3. The Cyberjaya project has been terminated (should be Angkasa Project) caused the big loss in the last QRs (caused by write-off of the land held for property development).
The co also has a plan to use the land for medical center to coop with the medical business expansion.
4. Expected revenues from medical (RM10 mil) and construction (RM28 mil) for FY Ended 31 July 2021.
5. The big losses in 4th QR 2020 is from one-off items. Not to be incurred in the next QR reports.
6. The co is positively believes that the medical and construction will be able to contribute for a better net operating cash flow.
7. On the risk to be GN3 listing issuer. The risk is smaller because medical and construction businesses will help the co to increase the shareholders equity and eliminates the possibility of the co to be listed as GN3 listing co.
13/01/2021 9:30 AM
MZM2511 The new engine of growth for Nexgram..
1. Covid-19 Test Kits (agreement with MKN/MOH and MTC)
2. Covid-19 Test (via subsidiary in Indonesia)
3. Tracvirus SafeTravelPass (Approved by MKN/ MOH))
4. Medical gloves and PPE (gown) (contract with MAPU in Indonesia)
5. NexgramBottleVaccine (via subsidiary operation)
6. RM118 mil Subcontract of the Gua Musang Highway (subcontract in progress)
7. Covid-19 VACCINE (plan to manufacture and distribute (JV with Rafarma))
13/01/2021 9:34 AM
DRwarrant COMINGGGGGGGGG....$$$$$
DEAL WITH CHINA & KOREA TOO
GREAT FUTURE for NEXGRAM COVID - VACCINE BUSINESS
13/01/2021 10:35 AM
8dragon With just a single bad news, Nexgram share will tumble....
13/01/2021 11:01 AM
Anwarmahadir I think DRwarant & 8dragon ARE THE SAME PERSON
13/01/2021 11:30 AM
Reiko8 Why didn't up
13/01/2021 11:54 AM
MZM2511 Why stagnant at 4.5-5.0 sen with a big volume bid to buy @4.5 sen?
No idea...
No clue...
No answers..???
13/01/2021 12:13 PM
MZM2511 New Brazil data shows disappointing 50.4% efficacy for China's CoronaVac vaccine

Source: https://www.theedgemarkets.com/article/new-brazil-data-shows-disappointing-504-efficacy-chinas-coronavac-vaccine

and, for comparison:

As per the release, Sputnik V currently ranks among top 10 candidate vaccines approaching the end of clinical trials and the start of mass production on the World Health Organization's (WHO) list.

The vaccine's efficacy is confirmed at 91.4 per cent based on data analysis of the final control point of clinical trials in Russia, the release said. Currently, the vaccine's clinical trials are underway in the UAE, Egypt, Venezuela and Belarus while it has been registered in Algeria, Argentina, Belarus, Bolivia and Serbia for inoculation.

Source: https://www.newkerala.com/news/2021/6586.htm
13/01/2021 12:17 PM
MZM2511 Pembekal Sputnik V dari Russia memang mencari partners dari negara lain untuk mengilang vaksin tersebut. Peluang ini terbuka untuk anak syarikat Rafarma di Russia untuk cuba deal untuk JV: . . .....While the Russian Direct Investment Fund (RDIF), which has funded Sputnik V, has deals with multiple countries to supply millions of doses, only about 1.5 million doses of the vaccine have rolled out domestically.
..... The RDIF has said it plans to rely on manufacturing partners in China, India, South Korea and elsewhere to fulfill its major international supply deals

Source: https://news.yahoo.com
13/01/2021 12:19 PM
MZM2511 Sejak dari mula, Sinovac vaccine memang ada masalah dari segi laporan ujian keberkesanannya:

1. China’s Sinovac COVID-19 Vaccine Less Effective than Initially Thought

Source: https://www.voanews.com/covid-19-pandemic/chinas-sinovac-covid-19-vaccine-less-effective-initially-thought

2. Sinovac's Covid-19 vaccine 78% effective in late-stage trial in Brazil — source
Source: https://www.theedgemarkets.com/article/sinovacs-covid19-vaccine-78-effective-latestage-trial-brazil-%E2%80%94-source

3. New Brazil data shows disappointing 50.4% efficacy for China's CoronaVac vaccine
Source: https://www.theedgemarkets.com/article/new-brazil-data-shows-disappointing-504-efficacy-chinas-coronavac-vaccine

4. Coronavirus: Scientists concerned by way data from Chinese drug firm Sinovac’s vaccine trials is coming out

Source: https://sg.news.yahoo.com/coronavirus-scientists-concerned-way-data-140100178.html
13/01/2021 12:33 PM
terranova1275 These news are all rubbish
13/01/2021 2:06 PM
MZM2511 Yes. Nexgram company is a rubbish collector company. The rubbish will be recycle to be reusable goods. It will has a better earnings and going to be in black again. He He
13/01/2021 2:19 PM
8dragon Nexgram can Tapao from ACE market already and get lost from klse..... Otherwise many retailers will be cheated and going to wrap up as bankrupts....
13/01/2021 2:46 PM
jennyhee MZM2511 yeah 3 feet from Gold
13/01/2021 2:51 PM
DRwarrant No laahh....Don't be POND*N 8Dragon....
You better buy an Old fashioned Risk Free Grandma FD/ Fixed deposit for a never failed peanut 2 % in a year !!
13/01/2021 2:56 PM
gulamerah No point to argue, the market is always correct.
13/01/2021 3:36 PM
DRwarrant Pretty sure NEXGRAM SET TO COME ANYTIME $$$$$
After all NEXGRAM is ALL ROUNDER COVID & VACCINE LAB - BOTTLINGG !
FANTASTIC YEAR 2021 $$$$$$
13/01/2021 5:10 PM
MadCow75 rocket launch tomolo...
13/01/2021 5:55 PM
TunPika Go Nexgram

NexgramBottleVaccine..
RallyVaccineGameOn..
Time2Fly.... $$$$$$$$
13/01/2021 7:18 PM
TunPika 2021 year for nexgram
to be the main head
of counter vaccines..

Go Nexgrammmmmm
13/01/2021 7:25 PM
OKU_2220 8dragon : Nexgram can Tapao from ACE market already and get lost from klse..... Otherwise many retailers will be cheated and going to wrap up as bankrupts....

*************************************************************************
If Nexgram can Tapao... Then why u still in this bloody forum....
Everyday come out and talk cock...
U go others counter la..... Talk like Ah Qua...
How many month u said GN3 / PN17 & bankrupts... but until now u still here...
Means this counter can play... if not.. why u waste so many hour watching this counter...

Useless fella.....
U bangkrupt & Pok Kai...
Nexgram still here
13/01/2021 8:37 PM
MadCow75 if lucky nexgram dapat korek gold mine (botteling) break leg jo... makan tak habis...
14/01/2021 12:04 AM
8dragon Nexgram will remain below 5 cents for the rest of the year....
14/01/2021 7:11 AM
DRwarrant @8dragon must drink MACHO tonic to overcome POND*N trader syndrome..

NEXGRAM >> STEAMINGGG anytime given the WORSENING COVID + VACCINE EUPHORIA = $$$$$ to NEXGRAM
14/01/2021 9:06 AM
8dragon Wow, tomorrow 4 cents..... Lol
14/01/2021 10:07 AM
DRwarrant @8dragon...Keep On Waiting till Cats Grow HORN { Kucing tumbuh Tandok }
14/01/2021 10:20 AM
stephenkai1996 The value of this company is not just the current prices. It should be higher than that. Should put more effort on it.
14/01/2021 10:56 AM
8dragon I think our KJ will prefer to import the vaccine bottle in bulk at a very much lower cost than locally manufactured bottle... this will give Nexgram another blow....
14/01/2021 11:56 AM
MZM2511 8dragon. If we rely on your logic, I want to suggest all the plastic/bottle manufacturer in Malaysia to be banned to operate.
After that the goverment of Malaysia should give permission to import plastic goods and bottles tax free.
BUY LOCALL PRODUCT LAST. He He
14/01/2021 12:36 PM
8dragon @ NZM2511....., I mean the possibility behind it as our politicians like to award contracts to their cronies... don't u think so.. lol
14/01/2021 1:10 PM
8dragon Sorry....*MZM2511
14/01/2021 1:11 PM
MZM2511 About to grant contract to their cronies... This one I agree. He He
14/01/2021 1:22 PM
DRwarrant @8dragon...Pity on You...
You very risk averse @ pond*n trader better buy No risk Old fashioned grandma Bank FD@Fixed Deposit for a never failed Peanut /Chicken Feed 2 % in 1 year..
# BTW.. NEXGRAM KAKIs will be rewarded with handsome ANGPOWS $$$$$ this CNY/Chinese New Year .
14/01/2021 1:26 PM
MZM2511 That's why I prefer to relate the covid-19 vaccine deal more on Sputnik V as the JV candidate. I believe that Rafarma's subsidiary in Russia can negotiate for the JV participation in the Malaysian Goverment effort to secure the Sputnik V vaccine for Malaysia... Keep dreaming.. Brother
14/01/2021 1:34 PM
DRwarrant Covid-19 (Jan 14) - 3,337 record all time high new cases, 15 deaths

Published 14 Jan 2021, 6:21 pm
Modified 7:52 pm

COVID-19 | The Health Ministry today reported 15 new Covid-19 deaths amidst a new all time record high of 3,337 new cases.
-----------------------------------

Further Good News to Nexgram Covid -Vaccine Bottling -Lab Business = $$$$$$ !!
14/01/2021 8:01 PM
DRwarrant NEXGRAM LOOKS ATTRACTIVE & PROMISINGG given the WORSENING COVID & VACCINE BOTTLING DEMAND.....

Potential to get BIG CNY / Chinese New Year angpows = $$
15/01/2021 9:41 AM
DRwarrant Covid-19 (Jan 15): 3,211 new cases, record ICU usage ....Pergghhhh.... !
That's why this Nexgram is Stabilize -Can't Down , ONLY to UP ANYTIME ..... already 3 weeks under collection .
Be patient......as the Covid Pandemic remained Worst >> DAMN GOOD to NEXGRAM COVID BUSINESS !

#Have Faith ON NEXGRAM >>
POTENTIAL NEXT WEEK $ - CNY@ Chinese New Year RALLY IS AROUND THE CORNER ..!!
15/01/2021 11:35 PM
8dragon Nexgram looks attractive but no promising return on your investment...can you find a 5 cents share co that is dealing with the covid 19 related business..... definitely you won't find any.... so can you put your trust in Nexgram anymore...???
16/01/2021 9:15 AM
DRwarrant @8dragon..... Nexgram looks attractive but no promising return on your investment...can you find a 5 cents share co that is dealing with the covid 19 related business..... definitely you won't find any.... so can you put your trust in Nexgram anymore...???
16/01/2021 9:15 AM
--------------------------------
Good question 8Dragon/OKU_2020....WHY NOT ? The Big Angpows@Jackpot of 100 % is Waiting to smart investors when NEXGRAM hit 10 SEN before CNY@Chinese new year Feb 12 !!....if 20 sen >> 300 % Lottery $

## If RM 1 >> 1,900 % to MZM2511 & CO......{ 95 sen / 5 sen X 100 = 1,900 % }
MZM2511 investment of 100 K to EXPLODE to RM 1.9 Million ( RM 1,900,000-00 )....GOD WILLING..!!

Yesss...Nexgram is the Cheapest Covid - Vaccine related Stock . As this Covid pandemic is getting worst , like it OR not ...sooner or later Nexgram got to Go UP too in tandem with other covid-vaccine counters .
16/01/2021 12:12 PM
chinaman gomen use wrong way. only foreign workers who pass covid test, allowed to operate....5 million legal, illegal foreign workers but only over 100,000 tested. still a long long way to go. our test process too damn slow.... see the big market untapped yet locally??
16/01/2021 2:13 PM
DRwarrant @chinaman....
BIG POTENTIAL BUSINESS for NEXGRAM COVID/VACCINE TO COME = BIG MONEY $$$$$
16/01/2021 3:37 PM
DRwarrant Covid-19: New record ALL TIME HIGH of 4,029 daily cases, 8 fatalities bring death toll to 594
...further GOOD NEWS to Nexgram Covid - Vaccine Business = $$$$$
16/01/2021 9:30 PM
DRwarrant Chinese city reports coronavirus found on ice cream...!
Frightening Covid.....HELP....HELPPP !
17/01/2021 5:00 PM
terranova1275 Covid cases high...good news???!! F$CK
17/01/2021 6:22 PM